Real-world check: how does zanubrutinib affect daily life for blood cancer patients?
NCT ID NCT05326308
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 34 times
Summary
This study follows about 705 adults with Waldenström's macroglobulinemia, chronic lymphocytic leukemia, marginal zone lymphoma, or follicular lymphoma who are already taking or starting zanubrutinib. Researchers will track hospital visits, emergency room use, and quality of life through questionnaires. The goal is to understand how the drug works outside of clinical trials, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lübecker Onkologische Schwerpunktpraxis
RECRUITINGLübeck, Schleswig-Holstein, D-23562, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsklinikum Salzburg, Klinik für Innere Medizin III
RECRUITINGSalzburg, A-5020, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.